X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
SUN PHARMA Announces Quarterly Results (4QFY18); Net Profit Up 12.0%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA Announces Quarterly Results (4QFY18); Net Profit Up 12.0%
Mon, 28 May

SUN PHARMA has announced its results for the quarter ended March 2018. Here is a detailed performance review of the same:

SUN PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Mar-17*
3
Dec-17*
3
Mar-18*
QoQ ChangeYoY Change
Net SalesRs m71,37066,53269,7714.9%-2.2%
Other incomeRs m2,2451,2923,028134.3%34.9%
TurnoverRs m73,61567,82472,7997.3%-1.1%
ExpensesRs m55,89551,99952,9361.8%-5.3%
Gross profitRs m15,88514,53416,83515.8%6.0%
DepreciationRs m3,3823,3934,55234.2%34.6%
InterestRs m4509531,55463.0%245.4%
Profit before taxRs m14,29911,47913,75619.8%-3.8%
TaxRs m4437,487-1,767-123.6%-498.8%
Profit after taxRs m13,8563,99215,523288.8%12.0%
Gross profit margin%22.321.824.1
Effective tax rate%3.165.2-12.8
Net profit margin%18.85.921.3
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter fell 2.2% on a year-on-year (YoY) basis. The expenses were down by 5.3% YoY during the same period.
  • The company's operating profit increased by 6.0% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 24.1% in 4QFY18 as against 22.3% in 4QFY17.
  • Depreciation charges and finance costs increased by 34.6% YoY and 245.4% YoY, respectively.
  • Other income increased by 34.9% YoY during the quarter.
  • Net profit for the quarter increased by 12.0% YoY. Net profit margins during the quarter increased from 18.8% in 4QFY17 to 21.3% in 4QFY18.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter fell 4.9% on a quarter-on-quarter (QoQ) basis. The expenses were up by 1.8% QoQ during the same period.
  • The company's operating profit increased by 15.8% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 24.1% in 4QFY18 as against 21.8% in 3QFY17.
  • Net profit for the quarter increased by 288.8% QoQ, while net profit margins increased from 5.9% in 3QFY17 to 21.3% in 4QFY18.

To see how SUN PHARMA has performed over the last eight quarters, please visit here.

SUN PHARMA Share Price Performance

Over the last one year, SUN PHARMA share price has moved up from Rs 568.6 to Rs 501.0, registering a Loss of Rs -67.6 or around 11.9%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 13,322.4 (up 2.1%). Over the last one year it has moved down from 13,590.9 to 13,322.4, a gain of -268.6 points (down 2.0%).

Overall, the S&P BSE SENSEX is up 0.9% over the year.

Current Valuations

At the current price of Rs 501.0, the price to earnings (P/E) ratio of SUN PHARMA stands at 40.8 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 3.3 times.

Equitymaster requests your view! Post a comment on "SUN PHARMA Announces Quarterly Results (4QFY18); Net Profit Up 12.0%". Click here!

  

Related Views on News

SUN PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 265.5% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, SUN PHARMA has posted a net profit of Rs 15 bn (up 265.5% YoY). Sales on the other hand came in at Rs 77 bn (up 16.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 20, 2018 | Updated on Dec 20, 2018

Here's an analysis of the annual report of SUN PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

SUN PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 110.7% (Quarterly Result Update)

Nov 14, 2018 | Updated on Nov 14, 2018

For the quarter ended September 2018, SUN PHARMA has posted a net profit of Rs 1 bn (down 110.7% YoY). Sales on the other hand came in at Rs 69 bn (up 4.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

More Views on News

Most Popular

3 Indian Stocks with Amazon-Like Potential(Profit Hunter)

Apr 10, 2019

We have identified 3 stocks with huge wealth building potential which meet our 'Click of a Button' criteria.

This Company is Making a Big Comeback and You Can Now Profit from Its Example(The 5 Minute Wrapup)

Apr 10, 2019

How Dell got its mojo back.

This is Why the Stock of Jubilant FoodWorks Went Up 1,160%(The 5 Minute Wrapup)

Apr 12, 2019

This critical business strategy has enabled companies to scale their operations faster.

Pocketing Massive Gains with HDFC And HDFC Bank(Profit Hunter)

Apr 12, 2019

Here's how one could have generated gains of Rs 59,250 in 10 days by trading HDFC and HDFC Bank with a capital of Rs 4 lakh.

A Simple 3-Point Investing Manifesto for You the Indian Investor(The 5 Minute Wrapup)

Apr 11, 2019

A must have checklist for every investor in the Indian stock market.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

CYIENT SHARE PRICE


Apr 23, 2019 11:19 AM

TRACK CYIENT

COMPARE CYIENT WITH

MARKET STATS